Xylem Inc. (NYSE:XYL) Shares Bought by Marshall Wace LLP

Marshall Wace LLP grew its stake in Xylem Inc. (NYSE:XYLFree Report) by 433.0% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 229,082 shares of the industrial products company’s stock after buying an additional 186,105 shares during the period. Marshall Wace LLP’s holdings in Xylem were worth $31,070,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. EverSource Wealth Advisors LLC lifted its holdings in shares of Xylem by 68.8% during the first quarter. EverSource Wealth Advisors LLC now owns 189 shares of the industrial products company’s stock worth $25,000 after purchasing an additional 77 shares during the period. Mark Sheptoff Financial Planning LLC acquired a new stake in Xylem during the 2nd quarter valued at approximately $33,000. Blue Trust Inc. boosted its holdings in shares of Xylem by 1,185.7% in the 2nd quarter. Blue Trust Inc. now owns 270 shares of the industrial products company’s stock valued at $35,000 after acquiring an additional 249 shares during the last quarter. FinTrust Capital Advisors LLC boosted its holdings in shares of Xylem by 170.9% in the 1st quarter. FinTrust Capital Advisors LLC now owns 317 shares of the industrial products company’s stock valued at $41,000 after acquiring an additional 200 shares during the last quarter. Finally, Hazlett Burt & Watson Inc. increased its stake in shares of Xylem by 184.9% in the first quarter. Hazlett Burt & Watson Inc. now owns 339 shares of the industrial products company’s stock worth $43,000 after acquiring an additional 220 shares during the period. 87.96% of the stock is currently owned by institutional investors and hedge funds.

Xylem Price Performance

Xylem stock opened at $134.15 on Friday. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.33 and a current ratio of 1.85. The company’s fifty day moving average price is $133.27 and its 200 day moving average price is $134.33. The stock has a market capitalization of $32.58 billion, a P/E ratio of 47.74, a P/E/G ratio of 2.34 and a beta of 1.04. Xylem Inc. has a 1 year low of $87.59 and a 1 year high of $146.08.

Xylem (NYSE:XYLGet Free Report) last released its earnings results on Tuesday, July 30th. The industrial products company reported $1.09 EPS for the quarter, topping analysts’ consensus estimates of $1.05 by $0.04. The business had revenue of $2.17 billion during the quarter, compared to analysts’ expectations of $2.14 billion. Xylem had a net margin of 9.11% and a return on equity of 9.48%. The company’s quarterly revenue was up 26.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.98 earnings per share. As a group, equities research analysts anticipate that Xylem Inc. will post 4.26 earnings per share for the current fiscal year.

Xylem Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, September 26th. Stockholders of record on Thursday, August 29th were given a $0.36 dividend. The ex-dividend date was Thursday, August 29th. This represents a $1.44 annualized dividend and a dividend yield of 1.07%. Xylem’s dividend payout ratio (DPR) is presently 51.25%.

Analysts Set New Price Targets

Several equities research analysts have commented on XYL shares. UBS Group assumed coverage on shares of Xylem in a report on Tuesday, August 13th. They issued a “buy” rating and a $165.00 price target on the stock. Oppenheimer upped their target price on Xylem from $147.00 to $152.00 and gave the stock an “outperform” rating in a research note on Friday, May 31st. Stifel Nicolaus lifted their price target on Xylem from $170.00 to $172.00 and gave the company a “buy” rating in a research report on Wednesday, July 31st. TD Cowen restated a “hold” rating and issued a $138.00 price objective on shares of Xylem in a research report on Tuesday, September 3rd. Finally, Royal Bank of Canada raised their price objective on shares of Xylem from $160.00 to $163.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 31st. Five equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $147.54.

View Our Latest Stock Report on Xylem

About Xylem

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Further Reading

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYLFree Report).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.